source
- Novartis to acquire Myricx Bio for $1.1 billion to expand antibody-drug conjugate pipelineNovartis announced it will buy London-based Myricx Bio, agreeing to pay $1.1 billion upfront. The deal gives Novartis access to Myricx's novel payload technology - an N-myristoyltransferase inhibi…
- Former Surgeon General Calls for Clinician-Guided Framework to Regulate Popular PeptidesJerome Adams, the former U.S. surgeon general, argues that the FDA should adopt a middle‑ground strategy rather than banning peptide compounds outright. He notes the rapid growth of peptide use for…